Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTSC
2551
DELISTED
MTS Systems Corp
MTSC
| $4.81M | ﹤0.01% |
273,556
-1,563
| -0.6% | -$28.9K |
|
|
PTR
2552
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $4.8M | ﹤0.01% |
145,099
+31,524
| +28% | +$1.11M |
|
2553
Live Oak Bancshares
LOB
$2.02B
| $4.79M | ﹤0.01% |
330,005
+14,921
| +5% | +$202K |
|
2554
Sterling Infrastructure
STRL
$16.6B
| $4.78M | ﹤0.01% |
456,608
+134,129
| +42% | +$1.24M |
|
2555
Transmedics
TMDX
$2.79B
| $4.78M | ﹤0.01% |
266,795
+97,856
| +58% | +$1.53M |
|
|
LAND
2556
Gladstone Land Corp
LAND
$352M
| $4.76M | ﹤0.01% |
300,313
+39,103
| +15% | +$547K |
|
2557
Voyager Therapeutics
VYGR
$189M
| $4.75M | ﹤0.01% |
376,739
+32,508
| +9% | +$378K |
|
|
CLCT
2558
DELISTED
Collectors Universe
CLCT
| $4.75M | ﹤0.01% |
138,671
+2,179
| +2% | +$49.5K |
|
2559
Seaboard Corp
SEB
$4.21B
| $4.75M | ﹤0.01% |
1,620
-102
| -6% | -$309K |
|
2560
CytomX Therapeutics
CTMX
$723M
| $4.74M | ﹤0.01% |
569,070
-6,350
| -1% | -$59K |
|
2561
Caesarstone
CSTE
$79.9M
| $4.74M | ﹤0.01% |
399,562
+135,141
| +51% | +$1.42M |
|
2562
Phathom Pharmaceuticals
PHAT
$684M
| $4.72M | ﹤0.01% |
143,453
+12,195
| +9% | +$469K |
|
2563
ImmunityBio
IBRX
$7.28B
| $4.72M | ﹤0.01% |
384,164
+308,693
| +409% | +$1.74M |
|
2564
Customers Bancorp
CUBI
$2.83B
| $4.71M | ﹤0.01% |
391,335
+19,424
| +5% | +$216K |
|
|
HIBB
2565
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $4.71M | ﹤0.01% |
224,670
-2,880
| -1% | -$48K |
|
|
QTNT
2566
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $4.7M | ﹤0.01% |
15,886
+15,358
| +2,909% | +$4.42M |
|
|
CATC
2567
DELISTED
CAMBRIDGE BANCORP
CATC
| $4.7M | ﹤0.01% |
79,353
+21,524
| +37% | +$1.13M |
|
2568
Beam Therapeutics
BEAM
$2.92B
| $4.68M | ﹤0.01% |
167,243
+36,217
| +28% | +$780K |
|
2569
iPath Select MLP ETN
ATMP
$632M
| $4.65M | ﹤0.01% |
428,835
-27,220
| -6% | -$298K |
|
|
CFB
2570
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $4.65M | ﹤0.01% |
475,208
+20,876
| +5% | +$191K |
|
2571
Nice
NICE
$6.05B
| $4.63M | ﹤0.01% |
24,482
-1,867
| -7% | -$327K |
|
2572
Gold Fields
GFI
$30.5B
| $4.63M | ﹤0.01% |
492,353
-26,224
| -5% | -$199K |
|
2573
Spyre Therapeutics
SYRE
$9.11B
| $4.62M | ﹤0.01% |
19,957
+8,106
| +68% | +$1.54M |
|
2574
Century Aluminum
CENX
$4.66B
| $4.59M | ﹤0.01% |
643,469
-27,643
| -4% | -$146K |
|
|
CDMO
2575
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $4.58M | ﹤0.01% |
697,577
+23,443
| +3% | +$131K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.